Results 91 to 100 of about 12,443,450 (160)

Molecular dynamics of select missense mutations of Apolipoprotein E and their implications in Hyperlipoproteinemia type III

Apolipoprotein E (Apo E) is involved in lipid metabolism and plays a crucial role in maintaining the balance of lipoprotein interactions within the body.
Ranvir Singh, Sumit Thakur, Balvinder Singh   +2 more
core   +1 more source

Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia

, 1986
A variant of apolipoprotein E, denoted apo E3-Leiden, has been identified in a 41-year-old male suffering from type III hyperlipoproteinemia with xanthomatosis. Apo E3-Leiden focus in the E3 position.
Havekes, L., Gevers Leuven, J., Wit, E.de   +2 more
core  

Characterization with zonal ultracentrifugation of LDL in type V hyperlipoproteinemia

, 1984
Low-density lipoproteins (density = 1.019-1.063 g/ml) were isolated in 10 subjects with type V hyperlipoproteinemia by ultracentrifugation in a zonal rotor under rate flotation conditions.
G. Baggio, MANZATO, ENZO, G. Baldo, G. Crepaldi, MARIN, RAFFAELLA, A. Gasparotto   +5 more
core  

Eruptive xanthomas as revealing sign of type V hyperlipoproteinemia in a patient with a psychotic syndrome

, 2002
We describe a 33-year-old man affected with a psychotic syndrome, who developed eruptive xanthomas on the knees, elbows, buttocks and neck. In addition, diabetes mellitus, obesity and alcohol abuse but no family history of hyperlipidemia could be ...
FARGNOLI, MARIA CONCETTA, Sordi E, Peris, K.   +2 more
core  

Effects of guar gum on plasma lipoproteins and apolipoproteins C-II and C-III in patients affected by familial combined hyperlipoproteinemia

, 1984
In recent years, guar gum has been shown to be a potent hypocholesterolemic agent. The effects of this fiber on triglycerides are less clear. In order to evaluate the influence of guar supplementation on plasma lipoproteins and apolipoprotein C-II (apoC ...
A. Davoli, COMINACINI, Luciano, BOSELLO, Ottavio, U. Garbin, ZOCCA, Isabella, F. Ferrari   +5 more
core  

Therapeutic strategies in hyperlipoproteinemia(a)

This thesis aims to describe the currently available therapy options for hyperlipoproteinemia(a). It also sheds light on newer therapies that are still under development.egységes, osztatlanáltalános ...
Ahmed, Shamail
core  

Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia) [PDF]

Arthritis & Rheumatism, 1968
openaire   +2 more sources

A Case of Pseudohomozygous Type II Hyperlipoproteinemia.

Skin research, 1992
Ozawa, Kentaro, Okada, Natsuko, Yoshikawa, Kunihiko, Ueyama, Yuhya, Matsuzawa, Yuji   +4 more
openaire   +1 more source

Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk

Arquivos Brasileiros de Cardiologia
Paulo Eduardo Ballvé Behr, Emilio Hideyuki Moriguchi, Iran Castro, Luiz Carlos Bodanese, Oscar Pereira Dutra, Paulo Ernesto Leães, Pedro Pimentel Filho   +6 more
doaj   +1 more source

Can Non-Pharmacological Treatment Promote Additional Benefit for Children with Familial Hypercholesterolemia Treated with Statins?

Arquivos Brasileiros de Cardiologia
Luiza Antoniazzi
doaj   +1 more source